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ABSTRACT
MicroRNA (miRNAs) are short noncoding RNA molecules involved in many cellular processes
and shown to play a key role in somatic cell induced reprogramming. We performed an array
based screening to identify candidates that are differentially expressed between dermal skin
fibroblasts (DFs) and induced pluripotent stem cells (iPSCs). We focused our investigations on
miR-145 and showed that this candidate is highly expressed in DFs relative to iPSCs and signifi-
cantly downregulated during reprogramming process. Inhibition of miR-145 in DFs led to the
induction of “cellular plasticity” demonstrated by: (a) alteration of cell morphology associated
with downregulation of mesenchymal and upregulation of epithelial markers; (b) upregulation
of pluripotency-associated genes including SOX2, KLF4, C-MYC; (c) downregulation of miRNA let-
7b known to inhibit reprogramming; and (iv) increased efficiency of reprogramming to iPSCs in
the presence of reprogramming factors. Together, our results indicate a direct functional link
between miR-145 and molecular pathways underlying reprogramming of somatic cells to iPSCs.
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SIGNIFICANCE STATEMENT
iPSCs can be generated directly and conveniently from healthy and affected individuals and
have very significant potential for regenerative medicine, disease modeling, basic biology, and
drug discovery studies. However, there are limitations in the technology and the induction pro-
cess, which is currently not well-understood. Recent studies indicate that short noncoding
RNAs, named miRNAs play an important role in various stages of somatic cell reprogramming
to iPSC. In this study, we performed an expression based analysis to identify candidate miRNAs
that are highly expressed in somatic cells but are downregulated during the reprogramming
process. This led us to identification of miR-145 as a key miRNA candidate involved in the
reprogramming process. In this manuscript, we show that miR-145 is highly expressed in
human dermal fibroblasts but significantly downregulated during the reprogramming process to
iPSC. Our data suggests that inhibition of miR-145 leads to induction of cellular plasticity as
demonstrated by mesenchymal to epithelial transition, upregulation of pluripotency markers,
and increased efficiency of reprogramming.
INTRODUCTION
Somatic cell induced reprogramming requires
comprehensive reconfiguration of cellular sig-
nalling pathways and molecular profiles,
including microRNAs (miRNAs). miRNAs are
short, noncoding RNA molecules (22 nucleo-
tides in length) that play crucial active role in
many cellular processes by post-transcriptional
regulation of specific messenger RNA (mRNA).
Although some miRNAs have been shown to
play an important role during various stages of
reprogramming [1–3], our detailed understand-
ing of how miRNAs regulate this process
remains elusive.
A number of studies have indicated that
pluripotent stem cells [encompassing human
embryonic stem cells (hESCs) and human
induced pluripotent stem cells (iPSCs)] express
a distinct set of miRNAs that underline the
maintenance of the pluripotent phenotype by
influencing various processes such as cell cycle,
epigenetic profile, and resistance to apoptosis
[3–5]. It is not surprising that some of those
pluripotency-associated miRNAs also play an
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important role in cellular reprogramming mainly through regu-
lation of mesenchymal to epithelial transition (MET), bypassing
senescence or regulating the expression of key pluripotency
factors. Among the later class, miR-145 has recently been
shown to inhibit stem cell properties and to regulate the
expression of OCT4, SOX2, KLF4, and c-MYC (further abbrevi-
ated as OKSM) in cancer and stem cells [6–12]. However, the
role of miR-145 in reprogramming of somatic cells to iPSCs has
not been elucidated.
Given the critical importance of miR-145 on the regula-
tion of OKSM factors and stem cell properties, we sought
to study in detail the role of miR-145 in reprogramming of
human dermal skin fibroblasts (DFs) to iPSCs. Our array
based expression analysis and reverse transcriptase quanti-
tative polymerase chain reaction (qPCR) indicated that miR-
145 is highly expressed in DFs when compared to iPSCs and
significantly downregulated during the reprogramming pro-
cess. Furthermore, inhibition of miR-145 in DFs resulted
in a change of morphology from a long-spindled fibroblast
to short-spindled cell shape associated with change of
mesenchymal/epithelial genes toward epithelial phenotype,
upregulation of SOX2, c-MYC, KLF4, downregulation of
miRNA let-7b, and enhanced the reprogramming efficiency,
suggesting a key role for this miRNA in somatic cell induced
reprogramming.
MATERIALS AND METHODS
See Supporting Information Materials.
RESULTS AND DISCUSSION
To get insights into the expression profile of miRNAs involved
in reprogramming process and to identify differentially
expressed miRNAs, we performed miRNA expression analysis
between DFs and iPSCs using Agilent human miRNA microar-
ray. 38 miRNAs were significantly upregulated in iPSCs com-
pared to DFs (Supporting Information Table 1) and 51 miRNAs
were significantly upregulated in DFs compared to iPSCs (Sup-
porting Information Table 2). The criteria for significant upreg-
ulation/downregulation were more than threefold change of
expression and p value (<.05).
Inspection of predicted target genes suggests that these 89
miRNAs may be central to reprogramming. Likely target genes
(Supporting Information Tables 1 and 2) include important his-
tone deacetylases/methyltransferases, transcriptional repressors,
chromatin modifiers, polycomb repressive complex members,
DNA methylases, cell cycle regulators, p53 processing proteins,
and so on. The impact of DNA methylase and histone deacety-
lase inhibition on reprogramming underlines the potential
Figure 1. Expression of miR-145, miR-143, Let-7b, miR-18a, miR-367, and miR-363 at specific stages of reprogramming of DFs to
iPSCs, as determined by reverse transcriptase quantitative polymerase chain reaction. Error bars show SD of three independent
experiments using three different cell lines. Stars show statistical significance of miR-145 expression between DFs and cells at specific
stage of reprogramming (*, p< .05; **, p< .01; ***, p< .001). Abbreviations: DFs, dermal skin fibroblasts; iPSCs, induced pluripotent
stem cells.
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importance of these 89 miRNAs in controlling epigenetic regula-
tion and hence the reprogramming process. Of the 89 candi-
dates, we applied two selection criteria for identification of
study candidates: (a) highly expressed in DFs relative to iPSCs
and (b) miRNAs shown to regulate pluripotency factors. This led
to selection of miR-145 as a key candidate for this study.
In order to assess the expression of miR-145 at specific
stages of reprogramming and confirm the array results, we
transduced DFs with OKSM using CytoTune kit, harvested cells
every 6 days, and assessed the expression of selected miRNAs
(miR-145, miR-143, Let-7b, miR-18a, miR-367, and miR-363).
As shown on Figure 1, the expression of miR-145 was signifi-
cantly downregulated as early as day 6 post-transduction,
thus corroborating previously published data in pluripotent
stem cells [4, 5, 11]. Furthermore, all the other qPCR tested
miRNAs displayed the same expression pattern change as
revealed by the microarray study.
Since miR-145 is highly expressed in DFs and it is rapidly
downregulated upon reprogramming to iPSCs, we hypothe-
sized that its downregulation may lead to improved reprog-
ramming. Using lentiviral particles containing miR-145
inhibitor and mCherry reporter, we generated DFs cell lines
stably inhibiting miR-145. In order to test, if miR-145 was
inhibited, we scanned miRTarBase (version 4.5), a database of
experimentally validated miRNA targets (http://mirtarbase.
mbc.nctu.edu.tw/), for genes that are regulated by miR-145.
Figure 2. miR-145 target validation. (A): Summary of miR-145 targets including target sites predicted by miRTarBase. (B): DFs stably
expressing miR-145 inhibitor including mCherry reporter. The expression of mCherry reporter was determined using fluorescence micros-
copy and flow cytometry. Scale bar5 100 lm. (C): Western blot analysis of miR-145 targets and mesenchymal/epithelial markers in der-
mal skin fibroblasts (DFs) cell lines stably expressing miR-145 inhibitor. b-Actin was used as a loading control. This is a representative
example of at least three independent biological replicates in the three DFs used in this study. (D): Optical density of bands generated
by Western blot analysis shown as fold change in expression in miR-145 inhibited versus control transfected samples (n5 3). Stars show
statistical significance (*, p< .05; **, p< .01).
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We selected seven target genes (Fig. 2A) and tested their
expression upon miR-145 inhibition at protein level using
Western blot analysis. As shown on Figures 2C, 2D, we
detected upregulation of SOX2, KLF4, c-MYC, OCT4, CDK4,
MDM2, and WIP1 indicating that miR-145 was inhibited.
Notably, upon the inhibition of miR-145 cells changed their
shape from long-spindled fibroblast shape to a short-spindle
epithelial morphology (Fig. 2B), suggesting a possible mesen-
chymal to epithelial transition. In order to test, whether miR-
145 inhibition affects the expression of mesenchymal/epithelial
markers, we performed Western blot analysis of target proteins
involved in MET process in DFs. As shown on Figures 2C, 2D,
inhibition of miR-145 upregulated the expression of E-cadherin,
ZO-1, and reduced the expression of N-cadherin and Vimentin,
indicating downregulation of key mesenchymal and upregula-
tion of epithelial markers. Wound healing and migration assays
also indicated a slower migration capacity of cells transfected
with miR-145, providing further proof on the role of this
miRNA in MET transition (Supporting Information Fig. S1). Con-
trary to these findings, mesenchymal marker Snail was signifi-
cantly upregulated, suggesting that miR-145 inhibition was not
sufficient to fully promote/induce MET. Furthermore, Snail has
Figure 3. Characterization of DFs transiently inhibiting miR-145. (A): Morphology of human DFs transiently transfected by synthetic
miR-145 inhibitor 48 hours after transfection, as determined by light microscopy. Scale bar5 100 lm. (B): Western blot analysis of miR-
145 targets and mesenchymal/epithelial markers in DFs cell lines transiently inhibiting miR-145. b-Actin was used as a loading control.
This is a representative example of at least three independent biological replicates in the three DFs used in this study. (C): Optical den-
sity of bands generated by Western blot analysis (n5 3). (D): Let-7b expression upon transient inhibition (24 hours) of miR-145 in DFs,
as determined by reverse transcriptase quantitative polymerase chain reaction. Error bars show SD of four independent experiments
across three independent DFs used in this study. Stars show statistical significance (*, p< .05).
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been shown to be expressed during the early stages of reprog-
ramming and to be a strong enhancer of reprogramming acting
via the downregulation of miRNA let-7 family [13, 14], and
therefore upregulation of Snail expression may be more related
to enhancement of iPSC generation rather than MET transition.
Given the importance of MET in the first steps of reprogram-
ming process [15–18], changes in expression of mesenchymal/epi-
thelial markers and pluripotency markers upon miR-145 inhibition
in DFs (Fig. 2B–2D), we speculated that the efficiency of iPSCs
generation could be enhanced by the inhibition of miR-145 in
DFs. Since stable inhibition of miR-145 does not allow to inhibit
miR-145 at specific stage, and DFs stably expressing miR-145
inhibitor undergo senescence after approximately two to three
passages, presumably by intensive selection for hygromycin resist-
ance (data not shown), we transfected DFs with a synthetic miR-
145 inhibitor which led to significant downregulation of miR-145
(Supporting Information Fig. S2). Transient inhibition of miR-145
in DFs led to the induction of similar morphology as in case of
stabile inhibition (Fig. 3A). Furthermore, it led to downregulation
of mesenchymal markers, upregulation of epithelial markers, and
upregulation of SOX2, KLF4, and c-MYC (Fig. 3B, 3C; Supporting
Information Fig. S3). For the majority of the markers tested,
these impacts were more pronounced at 24–48 hours post-miR-
145 inhibition very likely due to transient nature of miR-145 inhi-
bition used for this assay. Notably, upregulation of Snail was
observed upon both stable and transient inhibition of miR-145
(Figs. 2C, 2D, 3B, 3C). In order to test, if inhibition of miR-145
downregulates let-7 via upregulation of Snail, we compared the
expression of let-7b in nontransfected DFs versus DFs with transi-
ently inhibited miR-145. We found that let-7b was downregulated
by approximately 20% upon inhibition of miR-145 (Fig. 3D), indi-
cating a possible link between miR-145 and let-7 during
reprogramming.
To assess how inhibition of miR-145 affects iPSCs genera-
tion efficiency, we transiently transfected DFs with miR-145
inhibitor at day 0. The next day cells were transduced with
OKSM and 23 days later the efficiency of iPSCs generation
was determined by counting of AP-positive and TRA-1-60-
positive colonies (Fig. 4A for a representative summary). The
inhibition of miR-145 at day 0 increased the reprogramming
efficiency by approximately twofold (Fig. 4B, 4C); however
inhibitor at later stages (day 7) did not significantly increased
iPSCs generation (data not shown).
miR-143 and miR-145 belong to the same miRNA cluster
and is possible that there may exist functional redundancy
between these two miRNAs. To investigate this further, we
performed single miR-143 inhibition and combined miR-143
and miR-145 inhibitions, but we did not see a significant
increase in reprogramming efficiency in either case (data not
shown). Furthermore, miRTarBase analysis indicated different
subsets of target genes for each of these two miRNAs, sug-
gesting lack of functional redundancy.
SUMMARY
Taken together, out data show that the expression of miR-145
is rapidly downregulated during reprogramming of somatic
cells into iPSCs. Furthermore, inhibition of miR-145 in DFs
downregulates mesenchymal markers, upregulates epithelial
markers, upregulates SOX2, KLF4, and c-MYC expression, and
downregulates let-7b, thus facilitating and enhancing reprog-
ramming of DFs to iPSCs.
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